Abbonarsi

Notch signaling contributes to the establishment of sustained unresponsiveness to food allergens by oral immunotherapy - 04/03/21

Doi : 10.1016/j.jaci.2020.07.011 
Toshiyuki Yoneyama, MD a, Nobuhiro Nakano, PhD b, , Mutsuko Hara, PhD b, Hiromichi Yamada, MD a, Kumi Izawa, MD, PhD b, Koichiro Uchida, MD, PhD c, Ayako Kaitani, PhD b, Tomoaki Ando, MD, PhD b, Jiro Kitaura, MD, PhD b, Yoshikazu Ohtsuka, MD, PhD a, Hideoki Ogawa, MD, PhD b, Ko Okumura, MD, PhD b, Toshiaki Shimizu, MD, PhD a
a Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan 
b Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan 
c Juntendo University Advanced Research Institute for Health Science, Tokyo, Japan 

Corresponding author: Nobuhiro Nakano, PhD, Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.Atopy (Allergy) Research CenterJuntendo University Graduate School of Medicine2-1-1 HongoBunkyo-kuTokyo113-8421Japan

Abstract

Background

Oral immunotherapy (OIT) aims to establish desensitization and sustained unresponsiveness (SU) in patients with food allergy by ingestion of gradually increasing doses of specific food allergens. However, little is known about the mechanisms by which OIT induces SU to specific allergens.

Objectives

We investigated the role of Notch signaling, which controls cell fate decisions in many types of immune cells in the induction of SU by OIT treatment.

Methods

Two types of mouse models, ovalbumin-induced food allergy and OIT, were generated. To elucidate the role of Notch signaling in OIT-induced SU, mice were intraperitoneally injected with the Notch signaling inhibitor N-[(3,5-difluorophenyl)acetyl]-l-alanyl-2-phenylglycine-1,1-dimethylethyl ester during the OIT treatment period.

Results

Ovalbumin-sensitized mice were desensitized and also had SU induced by OIT treatment, whereas repeated challenges with ovalbumin caused the development of severe allergic reactions in ovalbumin-sensitized mice. Administration of N-[(3,5-difluorophenyl)acetyl]-l-alanyl-2-phenylglycine-1,1-dimethylethyl ester to mice during the OIT treatment period inhibited the establishment of SU to ovalbumin but did not affect the induction of desensitization. OIT induced a systemic expansion of IL-10–producing CD4+ T cells, including TH2 cells, and myeloid-derived suppressor cells (MDSCs), particularly the monocytic MDSC subpopulation. Inhibition of Notch signaling prevented the OIT-induced expansion of those cells. In vitro cultures of bone marrow cells showed that Notch signaling directly promoted the generation of monocytic MDSCs. In addition, the contribution of MDSCs to OIT-induced SU was confirmed by MDSC depletion with the anti-Gr1 antibody.

Conclusion

Notch signaling contributes to the establishment of SU induced by OIT through systemic expansion of immunosuppressive cells, such as IL-10–producing CD4+ T cells and MDSCs.

Il testo completo di questo articolo è disponibile in PDF.

Graphical abstract




Il testo completo di questo articolo è disponibile in PDF.

Key words : Food allergy, oral immunotherapy, sustained unresponsiveness, Notch signaling, myeloid-derived suppressor cell

Abbreviations used : DAPT, DLL1, iNOS, LP, MDSC, Mo-MDSC, OFC, OIT, PMN-MDSC, SU, Treg


Mappa


 Supported in part by the Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research program (grant 18K08416) and Research Grant 2018 from the Foundation for Dietary Scientific Research.
 Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.


© 2020  American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 147 - N° 3

P. 1063 - Marzo 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Microbiome-induced antigen-presenting cell recruitment coordinates skin and lung allergic inflammation
  • Niki D. Ubags, Aurélien Trompette, Julie Pernot, Britt Nibbering, Nicholas C. Wong, Céline Pattaroni, Alexis Rapin, Laurent P. Nicod, Nicola L. Harris, Benjamin J. Marsland
| Articolo seguente Articolo seguente
  • Allergome-wide peptide microarrays enable epitope deconvolution in allergen-specific immunotherapy
  • Maria Mikus, Arash Zandian, Ronald Sjöberg, Carl Hamsten, Björn Forsström, Morgan Andersson, Lennart Greiff, Mathias Uhlén, Mattias Levin, Peter Nilsson, Marianne van Hage, Mats Ohlin

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.